Shanxi Chengcheng Technology

Shanxi Chengcheng Technology Co., Ltd. is a pharmaceutical company based in Taiyuan, Shanxi Province, China, primarily focused on the research and development of innovative Traditional Chinese Medicine (TCM) for cardiovascular disorders. The company’s flagship product, Gua Xie Xin Tong Dripping Pills (瓜薤心通滴丸), is a clinical-stage TCM therapy indicated for the treatment of coronary heart disease and angina pectoris. Developed in collaboration with the Chinese Academy of Chinese Medical Sciences and Hubei Fuguang Pharmaceutical, the drug has completed Phase 2 trials and is currently undergoing Phase 3 clinical investigation. Shanxi Chengcheng Technology’s research portfolio is recognized for its contribution to modernizing TCM treatments through rigorous clinical validation and has received support from China's National Health Commission.